This is a very good report. They can see strong growth coming from sales in the personal wheezometer. This is the asthma device that can give a reading on how severe a persons asthma is. Obvioulsy this device will be used by parents with young children and could be sold all over the globe. KSX is becoming a compelling investment oportunity and is clearly a stand out performer in this sector. Going a lot higher from here.
- Forums
- ASX - By Stock
- KSX
- rm research
rm research , page-3
Featured News
Add KSX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online